Fulcrum Therapeutics (FULC) Non-cash Items (2019 - 2026)

Fulcrum Therapeutics (FULC) has disclosed Non-cash Items for 7 consecutive years, with $61.4 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items rose 1046.77% to $61.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.4 million through Dec 2025, up 1046.77% year-over-year, with the annual reading at $61.4 million for FY2025, 1311.39% up from the prior year.
  • Non-cash Items for Q4 2025 was $61.4 million at Fulcrum Therapeutics, up from $5.9 million in the prior quarter.
  • The five-year high for Non-cash Items was $75.6 million in Q3 2021, with the low at $3971.0 in Q2 2022.
  • Average Non-cash Items over 5 years is $14.3 million, with a median of $4.0 million recorded in 2021.
  • The sharpest move saw Non-cash Items crashed 99.9% in 2022, then skyrocketed 70130.35% in 2023.
  • Over 5 years, Non-cash Items stood at $1.5 million in 2021, then rose by 27.66% to $1.9 million in 2022, then soared by 701.74% to $15.1 million in 2023, then plummeted by 64.58% to $5.4 million in 2024, then soared by 1046.77% to $61.4 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $61.4 million, $5.9 million, and $5.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.